Oscar Health, Inc. (OSCR)
NYSE: OSCR · Real-Time Price · USD
16.44
+0.27 (1.67%)
At close: Apr 22, 2026, 4:00 PM EDT
16.30
-0.14 (-0.85%)
After-hours: Apr 22, 2026, 7:08 PM EDT
Oscar Health Analyst Ratings
Total Analysts
8
Consensus Rating
Hold
Price Target
$16.88
Upside
+2.68%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Sell → Hold Upgrades $10 → $16 | Sell → Hold | Upgrades | $10 → $16 | -2.68% | Apr 20, 2026 |
| UBS | UBS | Strong Sell → Hold Upgrades $12 → $17 | Strong Sell → Hold | Upgrades | $12 → $17 | +3.41% | Jan 9, 2026 |
| Barclays | Barclays | Sell → Hold Upgrades $13 → $18 | Sell → Hold | Upgrades | $13 → $18 | +9.49% | Jan 5, 2026 |
| Stephens & Co. | Stephens & Co. | Hold Initiates $17 | Hold | Initiates | $17 | +3.41% | Dec 11, 2025 |
| Piper Sandler | Piper Sandler | Hold → Buy Upgrades $13 → $25 | Hold → Buy | Upgrades | $13 → $25 | +52.07% | Nov 26, 2025 |
| Wells Fargo | Wells Fargo | Sell Maintains $14 → $11 | Sell | Maintains | $14 → $11 | -33.09% | Nov 13, 2025 |
| Barclays | Barclays | Sell Maintains $11 → $13 | Sell | Maintains | $11 → $13 | -20.92% | Nov 10, 2025 |
| UBS | UBS | Strong Sell Maintains $11 → $12 | Strong Sell | Maintains | $11 → $12 | -27.01% | Nov 7, 2025 |
Scott Fidel Goldman Sachs | Goldman Sachs | Hold Initiates $17 | Hold | Initiates | $17 | +3.41% | Oct 14, 2025 |
| Wells Fargo | Wells Fargo | Sell Maintains $10 → $14 | Sell | Maintains | $10 → $14 | -14.84% | Oct 7, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $14 → $13 | Hold | Maintains | $14 → $13 | -20.92% | Aug 14, 2025 |
| Baird | Baird | Buy → Hold Downgrades $28 → $14 | Buy → Hold | Downgrades | $28 → $14 | -14.84% | Jul 25, 2025 |
| Barclays | Barclays | Sell Maintains $17 → $11 | Sell | Maintains | $17 → $11 | -33.09% | Jul 23, 2025 |
| UBS | UBS | Hold → Strong Sell Downgrades $15 → $11 | Hold → Strong Sell | Downgrades | $15 → $11 | -33.09% | Jul 15, 2025 |
| Wells Fargo | Wells Fargo | Hold → Sell Downgrades $16 → $10 | Hold → Sell | Downgrades | $16 → $10 | -39.17% | Jul 11, 2025 |
| Barclays | Barclays | Sell Initiates $17 | Sell | Initiates | $17 | +3.41% | Jul 2, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.